Cargando…
Prenylcysteine oxidase 1, an emerging player in atherosclerosis
The research into the pathophysiology of atherosclerosis has considerably increased our understanding of the disease complexity, but still many questions remain unanswered, both mechanistically and pharmacologically. Here, we provided evidence that the pro-oxidant enzyme Prenylcysteine Oxidase 1 (PC...
Autores principales: | Banfi, C., Baetta, R., Barbieri, S. S., Brioschi, M., Guarino, A., Ghilardi, S., Sandrini, L., Eligini, S., Polvani, G., Bergman, O., Eriksson, P., Tremoli, E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455616/ https://www.ncbi.nlm.nih.gov/pubmed/34548610 http://dx.doi.org/10.1038/s42003-021-02630-z |
Ejemplares similares
-
Prenylcysteine Oxidase 1 Is a Key Regulator of Adipogenesis
por: Banfi, Cristina, et al.
Publicado: (2023) -
Prenylcysteine Oxidase 1 (PCYOX1), a New Player in Thrombosis
por: Banfi, Cristina, et al.
Publicado: (2022) -
Prenylcysteine oxidase 1 like protein is required for neutrophil bactericidal activities
por: Petenkova, Anastasiia, et al.
Publicado: (2023) -
Identification of DKK-1 as a novel mediator of statin effects in human endothelial cells
por: Pontremoli, Marta, et al.
Publicado: (2018) -
Data for proteomic analysis of Human monocyte-derived macrophages
por: Eligini, S., et al.
Publicado: (2015)